Evaluation of an artificial neural network to ascertain why there is a high incidence of hepatitis B in the Chinese population after vaccination

Computers in Biology and Medicine

Volumn 43, Issue 9, 2013, Pages 1167-1170

  Hongfei, Wang ^a   Yunyan, Zhao ^a   Fei, Yan ^a   Hui, Liu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Artificial neural network; Hepatitis B; Incidence; Vaccine

Indexed keywords

CHRONIC INFECTION; HEPATITIS B; HEPATITIS B SURFACE ANTIGEN; HOST IMMUNE RESPONSE; INCIDENCE; LIFE EXPECTANCIES; QUALITY OF LIFE; QUANTITATIVE EFFECTS;

CORRELATION METHODS; IMMUNE SYSTEM; NEURAL NETWORKS;

VACCINES;

HEPATITIS B SURFACE ANTIGEN;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CHINESE; HEPATITIS B; HUMAN; INCIDENCE; LIFE EXPECTANCY; POPULATION; PRIORITY JOURNAL; VACCINATION;

ARTIFICIAL NEURAL NETWORK; HEPATITIS B; INCIDENCE; VACCINE;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; NEURAL NETWORKS (COMPUTER); QUALITY OF LIFE; SOFTWARE; VACCINATION;

EID: 84880026224     PISSN: 00104825     EISSN: 18790534     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2013.05.021     Document Type: Article

References (36)

1. Wang Y., Jia J. Control of hepatitis B in China: prevention and treatment. Expert. Rev. Anti Infect. Ther. 2011, 9(1):21-25.
2. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., Zhang Y., Liu J., Gong X., Chen Y., Wang F., Zheng H., Wang F., Guo J., Jia Z., Ma J., Wang H., Luo H., Li L., Jin S., Hadler S.C., Wang Y. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J. Infect Dis. 2009, 200(1):39-47.
3. Shen L.P., Zhang Y., Wang F., Zhang S., Yang J.Y., Fang K.X., Yu T., Wang X.Y., Zhang W.Y., Bi S.L. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme. Epidemiol. Infect. 2011, 139(8):1159-1165.
4. Zhang L., Xu A., Yan B., Song L., Li M., Xiao Z., Xu Q., Li L. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination. Int. J. Infect. Dis. 2010, 14:e483-e488.
5. Ministry of health of the people's republic of china Year book of public health in the people's republic of china in 2003-2010 2010, 23-283. Peking Union Medical College Press.
6. Zou L., Zhang W., Ruan S. Modeling the transmission dynamics and control of hepatitis B virus in China. J. Theor. Biol. 2010, 262(2):330-338.
7. Poorolajal J., Mahmoodi M., Majdzadeh R., Nasseri-Moghaddam S., Haghdoost A., Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine 2010, 28(3):623-631.
8. Sanyal G., Shi L. A review of multiple approaches towards an improved hepatitis B vaccine. Expert Opin. Ther. Pat. 2009, 19(1):59-72.
9. Luo Z., Xie Y., Deng M., Zhou X., Ruan B. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Eur. J. Gastroenterol. Hepatol. 2011, 23(8):695-700.
10. Zhang H., Li Q., Sun J., Wang C., Gu Q., Feng X., Du B., Wang W., Shi X., Zhang S., Li W., Jiang Y., Feng J., He S., Niu J. Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China. Int. J. Med. Sci. 2011, 8(4):321-331.
11. Lu F.M., Zhuang H. Prevention of hepatitis B in China: achievements and challenges. Chin. Med. J. (Engl) 2009, 122(24):2925-2927.
12. http://www.indexmundi.com/.
13. Bertoletti A., Gehring A.J. The immune response during hepatitis B virus infection. J. Gen. Virol. 2006, 87(Pt 6):1439-1449.
14. Hui C.K., Lau G.K. Immune system and hepatitis B virus infection. J. Clin. Virol. 2005, 34(Suppl. 1):S44-S48.
15. Shimizu Y. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection. World J. Gastroenterol. 2012, 18(20):2443-2451.
16. Liu H., Ma Y., Wang H., Liu Q. Quantitative evaluation of the effect of the hepatitis B vaccine based on the HBsAg- and anti-HBs-positive rates in the Chinese population over the last 33 years. Vaccine 2012, 30(23):3483-3487.
17. Serati M., Salvatore S., Siesto G., Cattoni E., Braga A., Sorice P., Cromi A., Ghezzi F., Bolis P. Urinary symptoms and urodynamic findings in women with pelvic organ prolapse: is there a correlation? Results of an artificial neural network analysis. Eur. Urol. 2011, 60(2):253-260.
18. Cleophas T.J., Cleophas T.F. Artificial intelligence for diagnostic purposes: principles, procedures and limitations. Clin. Chem. Lab Med. 2010, 48(2):159-165.
19. Ennett C.M., Frize M., Charette E. Improvement and automation of artificial neural networks to estimate medical outcomes. Med. Eng. Phys. 2004, 26(4):321-328.
20. Naumovic R., Furuncic D., Jovanovic D., Stosovic M., Basta-Jovanovic G., Lezaic V. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy. Biomed. Pharmacother. 2010, 64(9):633-638.
21. Hirose H., Takayama T., Hozawa S., Hibi T., Saito I. Prediction of metabolic syndrome using artificial neural network system based on clinical data including insulin resistance index and serum adiponectin. Comput. Biol. Med. 2011, 41(11):1051-1056.
22. Shao Z.J., Zhang L., Xu J.Q., Xu D.Z., Men K., Zhang J.X., Cui H.C., Yan Y.P. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J. Med. Virol. 2011, 83(5):791-795.
23. Merrill R.M., Hunter B.D. Seroprevalence of markers for hepatitis B viral infection. Int. J. Infect. Dis. 2011, 15(2):e78-121.
24. Huang C.F., Lin S.S., Ho Y.C., Chen F.L., Yang C.C. The immune response induced by hepatitis B virus principal antigens. Cell Mol. Immunol. 2006, 3(2):97-106.
25. Chen C.C., Yen C.H., Wu W.Y., Hu S.W., Chen S.C., Bell W.R., Lee M.C. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin. Med. J. (Engl) 2007, 120(13):1155-1158.
26. Odusanya O.O., Alufohai E., Meurice F.P., Ahonkhai V.I. Five-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria. Hum. Vaccin. 2011, 7(6):625-629.
27. Ochirbat T., Ali M., Pagbajab N., Erkhembaatar L.O., Budbazar E., Sainkhuu N., Tudevdorj E., Kuroiwa C. Assessment of hepatitis B vaccine-induced seroprotection among children 5-10 years old in Ulaanbaatar, Mongolia. Biosci. Trends 2008, 2(2):68-74.
28. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., Zhang Y., Liu J., Gong X., Chen Y., Wang F., Zheng H., Wang F., Guo J., Jia Z., Ma J., Wang H., Luo H., Li L., Jin S., Hadler S.C., Wang Y. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27(47):6550-6557.
29. Alavian S.M., Fallahian F., Lankarani K.B. Implementing strategies for hepatitis B vaccination. Saudi J. Kidney Dis. Transpl. 2010, 21(1):10-22.
30. La Torre G., Nicolotti N., de Waure C., Chiaradia G., Specchia M.L., Mannocci A., Ricciardi W. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol. J. 2008, 5:84.
31. Aussem A., Tchernof A., de Morais S.R., Rome S. Analysis of lifestyle and metabolic predictors of visceral obesity with Bayesian Networks. BMC Bioinf. 2010, 11:487.
32. Weinstein L., Radano T.A., Jack T., Kalina P., Eberhardt J.S. Application of multivariate probabilistic (Bayesian) networks to substance use disorder risk stratification and cost estimation. Perspect. Health Inf. Manag. 2009, 6:1b.
33. Han B., Chen X.W. bNEAT: a Bayesian network method for detecting epistatic interactions in genome-wide association studies. BMC Genomics 2011, 12(Suppl. 2):S9.
34. Binder A., Nakajima S., Kloft M., Müller C., Samek W., Brefeld U., Müller K.R., Kawanabe M. Insights from classifying visual concepts with multiple kernel learning. PLoS One 2012, 7(8):e38897.
35. Wang S., Yao J., Petrick N., Summers R.M. Combining statistical and geometric features for colonic polyp detection in CTC based on multiple kernel learning. Int. J. Comput. Intell. Appl. 2010, 9(1):1-15.
36. Hinrichs C., Singh V., Xu G., Johnson S.C. Alzheimers disease neuroimaging initiative. Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage 2011, 55(2):574-589.